pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,619 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT785Endpoints586BioPharma Dive224onclive165BioSpace60Fierce Biotech59raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Edgewise heart drug passes key trial test
    <figure><div><img src="https://imgproxy.divecdn.com/-_-j1ksVvt--CzTabcyO04fqPKqSm8e8ryaYmMbBK0g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzg3Mjk4OTE3LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
    Weight loss drugs will be available through Medicare starting next month, thanks to a program that is supposed to be temporary but may be difficult to end
    STAT · 1mo ago↗ source
  • Neumora depression drug fails; EnGene to cut 50% of staff
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
← prev
page 27 of 65
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
BioPharma Dive · 1mo ago
↗ source
  • How supplement use changed over decades
    Medicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • STAT+: Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials
    As the saying goes, one man’s trash is another man’s treasure. Or as Verge Labs might put it, one company’s failed clinical trial … is that same company’s new AI…
    STAT · 1mo ago↗ source
  • [Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus
    <p>This podcast explores how leading Alzheimer’s experts are working to bridge the gap between clinical trial design and frontline care.</p>
    BioPharma Dive · 1mo ago↗ source
  • UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancer
    Glioblastoma is notoriously good at evading the immune system, making it particularly resistant to immunotherapy, but now researchers may have found a clever workaround. Scientists at the Universi…
    Endpoints · 1mo ago↗ source
  • Opinion: I’m an Alzheimer’s specialist. I still missed it in my own father
    “Alzheimer’s is not primarily a disease of old age. It is a decades-long biological process,” writes Elizabeth Bevins.
    STAT · 1mo ago↗ source
  • Opinion: Congress must reauthorize the Pandemic and All-Hazards Preparedness Act
    America’s next health emergency won’t wait for Washington, write W. Craig Vanderwagen and Jennifer B. Alton.
    STAT · 1mo ago↗ source
  • STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions
    As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
    STAT · 1mo ago↗ source
  • CMS seeks to close Medicare negotiation 'loophole'
    CMS has proposed a policy change that clarifies its stance on how products are grouped together for Medicare negotiations. Under the Inflation Reduction Act, biologics become eligible for Medicar…
    Endpoints · 1mo ago↗ source
  • FDA plans to keep Makary priorities on trials, China, deputy says
    PHILADELPHIA – Following the recent departures of FDA Commissioner Marty Makary and both of his center directors for drugs and biologics, the Trump administration will continue pushing their priori…
    Endpoints · 1mo ago↗ source
  • STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
    The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.
    STAT · 1mo ago↗ source
  • STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
    The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.
    STAT · 1mo ago↗ source
  • Takeda fortifies orexin potential with more Phase 3 data
    With a formidable new competitor set to enter the orexin development race, Takeda is out with new data that it hopes will reinforce market-leading potential. The additional results from Takeda’s…
    Endpoints · 1mo ago↗ source
  • Elicio’s KRAS cancer vaccine fails in Phase 2, shares plummet
    Elicio Therapeutics’ pancreatic cancer vaccine failed to improve outcomes in a mid-stage study, but the company is seeking funds to move ahead to a larger Phase 3 trial anyway. Elicio reported ...
    Endpoints · 1mo ago↗ source
  • STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
    After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.
    STAT · 1mo ago↗ source
  • Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data
    Plus news about Sanofi, PharmaMar, Jazz, Rhythm Pharmaceuticals, Spyre and Zymeworks 🇨🇳 Another obesity readout from China: Gan & Lee Pharmaceuticals, a China-based insulin specialist, anno…
    Endpoints · 1mo ago↗ source
  • STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds
    A new analysis found that results for less than half of the clinical studies registered in a key European database were reported within the required time frame.
    STAT · 1mo ago↗ source
  • Covid vaccination cut risk of adverse heart events, large study finds
    Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.
    STAT · 1mo ago↗ source
  • Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staff
    The Really Big Neuroscience Company is proving to be a Really Big Flop with each passing update. Neumora Therapeutics will discontinue its lead depression drug after it failed another two Phase 3…
    Endpoints · 1mo ago↗ source
  • Medicare drug price rule may target under-the-skin Keytruda and Opdivo
    <figure><div><img src="https://imgproxy.divecdn.com/yNFj1iOXXiGXHrvNzMITrI7Zf52PfwK1rovRc0StZW8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDQ3NTA1MDAwLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Six leaders working on LGBTQ+ inclusion in biopharma
    It’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...
    Endpoints · 1mo ago↗ source
  • Lilly scores early positive data for new JAK drug
    <figure><div><img src="https://imgproxy.divecdn.com/BektaG64-yby8Y5l-Eb4j51Y6ClyucnWH1-PThZhx4E/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDE0NDc0NzEzLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • J&J multiple myeloma drug gains edge in earlier stage disease
    <figure><div><img src="https://imgproxy.divecdn.com/cm_W-FdbiM9BbB0zoOGzQIxUTIYDjzY9Hg-zhECEdaE/g:nowe:208:253/c:1738:982/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS85MzMxNjUxLWZh…
    BioPharma Dive · 1mo ago↗ source